202 related articles for article (PubMed ID: 29568059)
1. Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.
Bellazzo A; Di Minin G; Valentino E; Sicari D; Torre D; Marchionni L; Serpi F; Stadler MB; Taverna D; Zuccolotto G; Montagner IM; Rosato A; Tonon F; Zennaro C; Agostinis C; Bulla R; Mano M; Del Sal G; Collavin L
Cell Death Differ; 2018 Jul; 25(7):1224-1238. PubMed ID: 29568059
[TBL] [Abstract][Full Text] [Related]
2. miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway.
Ni QF; Zhang Y; Yu JW; Hua RH; Wang QH; Zhu JW
Cell Prolif; 2020 Jan; 53(1):e12630. PubMed ID: 31713929
[TBL] [Abstract][Full Text] [Related]
3. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-556-3p promotes the progression of esophageal cancer via targeting DAB2IP.
Lu HB
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6816-6823. PubMed ID: 30402845
[TBL] [Abstract][Full Text] [Related]
5. miR-889 promotes proliferation of esophageal squamous cell carcinomas through DAB2IP.
Xu Y; He J; Wang Y; Zhu X; Pan Q; Xie Q; Sun F
FEBS Lett; 2015 Apr; 589(10):1127-35. PubMed ID: 25841337
[TBL] [Abstract][Full Text] [Related]
6. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
[TBL] [Abstract][Full Text] [Related]
7. DAB2IP Expression in Abdominal Aortic Aneurysm: EZH2 and mir-363-3p as Potential Mediators.
Legaki E; Klonaris C; Athanasiadis D; Patelis N; Sioziou A; Liakakos T; Gazouli M
In Vivo; 2019; 33(3):737-742. PubMed ID: 31028191
[TBL] [Abstract][Full Text] [Related]
8. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
[TBL] [Abstract][Full Text] [Related]
9. Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.
Bellazzo A; Di Minin G; Collavin L
Cell Death Differ; 2017 Jan; 24(1):15-25. PubMed ID: 27858941
[TBL] [Abstract][Full Text] [Related]
10. MiR-145 suppresses the motility of prostate cancer cells by targeting cadherin-2.
Zeng H; Huang Y; Liu Q; Liu H; Long T; Zhu C; Wu X
Mol Cell Biochem; 2021 Oct; 476(10):3635-3646. PubMed ID: 34043125
[TBL] [Abstract][Full Text] [Related]
11. Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells.
Epis MR; Giles KM; Kalinowski FC; Barker A; Cohen RJ; Leedman PJ
J Biol Chem; 2012 Oct; 287(42):35251-35259. PubMed ID: 22908221
[TBL] [Abstract][Full Text] [Related]
12. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.
Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J
Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646
[TBL] [Abstract][Full Text] [Related]
13. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-889 promotes cell proliferation in colorectal cancer by targeting DAB2IP.
Xiao Y; Li ZH; Bi YH
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3326-3334. PubMed ID: 31081086
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization.
Chen H; Pong RC; Wang Z; Hsieh JT
Genomics; 2002 Apr; 79(4):573-81. PubMed ID: 11944990
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.
Kong Z; Xie D; Boike T; Raghavan P; Burma S; Chen DJ; Habib AA; Chakraborty A; Hsieh JT; Saha D
Cancer Res; 2010 Apr; 70(7):2829-39. PubMed ID: 20332235
[TBL] [Abstract][Full Text] [Related]
17. MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A.
Mu H; Xiang L; Li S; Rao D; Wang S; Yu K
J Cell Biochem; 2019 Apr; 120(4):4987-4997. PubMed ID: 30302800
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-driven miR-1307-3p promotes hepatocellular carcinoma cell proliferation and invasion by modulating DAB2 interacting protein.
Chen S; Liu R; Wang H; Liu Q
Pathol Res Pract; 2022 Sep; 237():154066. PubMed ID: 35985237
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of DAB2IP in chemoresistance of prostate cancer cells.
Wu K; Xie D; Zou Y; Zhang T; Pong RC; Xiao G; Fazli L; Gleave M; He D; Boothman DA; Hsieh JT
Clin Cancer Res; 2013 Sep; 19(17):4740-9. PubMed ID: 23838317
[TBL] [Abstract][Full Text] [Related]
20. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.
Xie D; Gore C; Liu J; Pong RC; Mason R; Hao G; Long M; Kabbani W; Yu L; Zhang H; Chen H; Sun X; Boothman DA; Min W; Hsieh JT
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2485-90. PubMed ID: 20080667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
